Our study uncovered a significantly higher ERBB2 expression level in HL/60/ADM cells than in parental HL/60 cells, implicating that inhibiting ERBB2 can be a valid approach to antagonize ADM resistance in AML. This evidence concerns the gene ERBB2 and acute myeloid leukemia.